Maxwell Skor
Stock Analyst at Morgan Stanley
(0.52)
# 3,743
Out of 4,944 analysts
5
Total ratings
40%
Success rate
-16.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Maxwell Skor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Assumes: Overweight | $250 | $191.15 | +30.79% | 1 | Jul 3, 2025 | |
| SANA Sana Biotechnology | Assumes: Overweight | $12 | $3.33 | +260.36% | 1 | Jul 3, 2025 | |
| TCRX TScan Therapeutics | Assumes: Overweight | $10 | $1.77 | +464.97% | 1 | Mar 14, 2025 | |
| IVVD Invivyd | Maintains: Overweight | $9.5 → $3.55 | $0.79 | +347.67% | 2 | Nov 20, 2024 |
Ascendis Pharma
Jul 3, 2025
Assumes: Overweight
Price Target: $250
Current: $191.15
Upside: +30.79%
Sana Biotechnology
Jul 3, 2025
Assumes: Overweight
Price Target: $12
Current: $3.33
Upside: +260.36%
TScan Therapeutics
Mar 14, 2025
Assumes: Overweight
Price Target: $10
Current: $1.77
Upside: +464.97%
Invivyd
Nov 20, 2024
Maintains: Overweight
Price Target: $9.5 → $3.55
Current: $0.79
Upside: +347.67%